Clinical Trial Update: Observational Retrospective Study To Characterize and Assess Clinical Outcomes of Patients Receiving Tezepelumab in the Framework Of Use in Special Situations Prior to Commercialisation in Spain

View source ↗

Summary

A retrospective observational study to characterize clinical outcomes of patients treated with tezepelumab in special-use settings prior to commercialization in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Tezepelumab (tezepelumab)

Snippet

Sponsor: AstraZeneca | Conditions: Severe Asthma | Status: COMPLETED